New and updated preclinical and clinical data presented by biopharma firms at the American Society of Clinical Oncology's annual meeting, including: Aadi, Abbvie, Alkermes, Alkido, Allogene, Amphivena, Arcellx, Astrazeneca, Athenex, Biosight, Bolt, Candel, Celldex, Coherus, Constellation, Cullinan, Daiichi, Fate, G1, Genocea, Gilead, Greenwich, Harpoon, Heat, Hutchison, Ichnos, Immunocore, Immutep, Incyte, Innocare, Innovent, Iovance, Iteos, Junshi, Kinnate, Kite, Lyvgen, Merck & Co., Morphosys, Nanobiotix, Novartis, Origincell, Panbela, Ribon, Surface Oncology, TG, Tracon, Ultimovacs, Vincerx, Y-Mabs .